RNA
ATRIUM THERAPEUTICS INC Earnings
$13.76
Earnings Summary
Revenue | $0.86Mn |
Net Profits | $-237.1Mn |
Net Profit Margins | -27569.88% |
ATRIUM THERAPEUTICS INC’s revenue fell -71.07% since last year same period to $0.86Mn in the Q4 2025. On a quarterly growth basis, ATRIUM THERAPEUTICS INC has generated -93.11% fall in its revenue since last 3-months.
ATRIUM THERAPEUTICS INC’s net profit fell -131.87% since last year same period to $-237.1Mn in the Q4 2025. On a quarterly growth basis, ATRIUM THERAPEUTICS INC has generated -35.92% fall in its net profits since last 3-months.
ATRIUM THERAPEUTICS INC’s net profit margin fell -701.56% since last year same period to -27569.88% in the Q4 2025. On a quarterly growth basis, ATRIUM THERAPEUTICS INC has generated -1871.63% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.28 |
EPS Estimate Current Year | -1.28 |
ATRIUM THERAPEUTICS INC’s earning per share (EPS) estimates for the current quarter stand at -1.28 - a -3.23% fall from last quarter’s estimates.
ATRIUM THERAPEUTICS INC’s earning per share (EPS) estimates for the current year stand at -1.28.
Key Ratios
Earning Per Share (EPS) | 0 |
ATRIUM THERAPEUTICS INC’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the ATRIUM THERAPEUTICS INC has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-12 | -1.28 | 0 | 100% |
